Research output per year
Research output per year
Personal profile
Biography
Dr. Muhammad Sarfraz is an experienced researcher in the field of nano-medicine. In August 2022, he joined Ocular Therapeutic Research Group (OTRG) of PMBRC-SETU, Waterford-Ireland as a Technical Lead. He obtained his PhD degree in Pharmaceutics (2017) from School of Pharmacy of Huazhong University of Science and Technology (HUST), Wuhan-China and Post-Doc Fellowship (2018-2020) from College of Medicine of Henan University, Kaifeng-China. Since 2009, he is also engaged with School of Pharmacy of The University of Lahore, Lahore-Pakistan and now serving as an Associate Professor. He has supervised research projects of three Master students. There are three master and three PhD students under his supervision working on various nano-drug delivery systems such as liposome, nano-particle, nano-gel, nano-emulsion. Dr. Muhammad Sarfraz is highly motivated to work with pharmaceutical industries under the ubrella of PMBRC to provide pharmaceutical nanotechnology based solution to solve poor solubility and low bioavailability issues of the drug and products.
Expertise related to UN Sustainable Development Goals
In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. This person’s work contributes towards the following SDG(s):
Education/Academic qualification
PhD, Talilored Nano-liposomal co-delivery of oleanolic acid with anticancer drug in HepG2 cancer model at reduced risk of multiorgan toxicity, Huazhong University of Science and Technology
30 Sep 2013 → 30 Jun 2017
Award Date: 30 Jun 2017
Masters Degree, Development and IVIVC evaluation for aqueous based film coated ketoprofen matrix tablets, Islamia University
06 Feb 2007 → 30 Jun 2009
Award Date: 29 Jun 2009
Bachelors Degree, Pharmacy, Islamia University
06 Sep 2000 → 31 Dec 2004
Award Date: 31 Dec 2004
External positions
Associate Professor, The University of Lahore
01 Sep 2009 → …
Keywords
- RS Pharmacy and materia medica
- nanomedicine
- nanomaterial
- drug delivery
- Product Development
- Cancer
Fingerprint
Dive into the research topics where Muhammad Sarfraz is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
Design, synthesis, in-vitro biological screening and in-silico studies of 2-thioxodihydropyrimidinone based new aminomethylene scaffolds
Ayyaz, M., Sarfraz, M., Arshad, M., Yaqoob, A., Siddique, S. A., Hussain, S., Ali, M. A., Qureshi, A. M. & Rauf, A., 01 Mar 2024, In: Journal of Molecular Structure. 1299, 137153.Research output: Contribution to journal › Article › peer-review
3 Citations (Scopus) -
Enhanced intracellular accumulation and cytotoxicity of bortezomib against liver cancer cells using N-stearyl lactobionamide surface modified solid lipid nanoparticles
Mostafaei, F., Hemmati, S., Valizadeh, H., Mahmoudian, M., Sarfraz, M., Abdi, M., Torabi, S., Baradaran, B., Vosough, M. & Zakeri-Milani, P., 05 Jan 2024, In: International Journal of Pharmaceutics. 649, p. 123635 123635.Research output: Contribution to journal › Article › peer-review
5 Citations (Scopus) -
Fabrication and evaluation of anticancer potential of diosgenin incorporated chitosan-silver nanoparticles; in vitro, in silico and in vivo studies
Zaib, S., Shah, H. S., Khan, I., Jawad, Z., Sarfraz, M., Riaz, H., Asjad, H. M. M., Ishtiaq, M., Ogaly, H. A., Othman, G. & Ahmed, D. A. E. M., 01 Jan 2024, In: International Journal of Biological Macromolecules. 254, Pt 3, p. 127975 127975.Research output: Contribution to journal › Article › peer-review
1 Citation (Scopus) -
Endogenous hydrogen sulfide inhibition suppresses tumor growth by promoting apoptosis and pyroptosis in esophageal cancer cells
Wang, H. G., Wang, D., Sarfraz, M., Afzal, A., Jing, M. R., Zhang, Y. X., Cai, C. B., Qi, H. W., Chen, H. J., Li, T., Hu, S. J., Liu, H. X., Ji, X. Y. & Wu, D. D., 01 Dec 2023, In: Translational Oncology. 38, p. 101770 101770.Research output: Contribution to journal › Article › peer-review
Open Access3 Citations (Scopus) -
Potent heteroaromatic hydrazone based 1,2,4-triazine motifs: synthesis, anti-oxidant activity, cholinesterase inhibition, quantum chemical and molecular docking studies
Ahmed, K., Bashir, M., Bano, R., Sarfraz, M., Khan, H. U., Khan, S., Sharif, A., Waseem, A., Gilani, M. A., Batool, K., Idrees, R., Rauf, A., Saleem, R. S. Z. & Arshad, M., 01 Jul 2023, In: Journal of Molecular Structure. 1284, 135383.Research output: Contribution to journal › Article › peer-review
6 Citations (Scopus)
Activities
- 1 Editorial work
-
Frontiers in Pharmacology (Journal)
Sarfraz, M. (Editor)
01 Aug 2022 → 2023Activity: Publication peer-review and editorial work › Editorial work